Related Experiment Video
Updated: Mar 24, 2026
06:32
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
3.3K
The Basis of Oncoimmunology
A Karolina Palucka1, Lisa M Coussens2
1The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Cell
|March 12, 2016
Summary
Harnessing the immune system, particularly T cells, can overcome cancer heterogeneity and therapy resistance. Future research aims to improve cancer treatments by targeting inflammation and T-cell activity within the tumor microenvironment.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Cancer heterogeneity drives clonal survival and resistance to therapies.
- Immune responses, especially antigen-specific T cells, play a crucial role in controlling cancer.
- Current immunotherapeutics like adoptive T-cell transfer and checkpoint blockade demonstrate the potential of immune system modulation.
Purpose of the Study:
- To explore how the host immune system can be better utilized to enhance cytotoxic cancer therapy efficacy.
- To identify research frontiers essential for improving cancer treatment outcomes.
- To develop strategies for overcoming resistance to current cancer therapies.
Main Methods:
- Investigating methods to neutralize tumor-promoting inflammation.
- Exploring strategies for broadening T-cell repertoires, including vaccination.
- Elucidating mechanisms of immune cell organization within tumor microenvironments to regulate T-cell activity.
Main Results:
- Active immune responses, particularly T cells, shape cancer heterogeneity and influence therapy resistance.
- Immunotherapeutics highlight the potential of T cells in cancer control.
- Understanding immune cell interactions is key to modulating the tumor microenvironment.
Conclusions:
- Harnessing the immune system offers a powerful approach to enhance cytotoxic therapy and improve patient outcomes.
- Addressing tumor-promoting inflammation, expanding T-cell diversity, and understanding immune regulation are critical research areas.
- These efforts will lead to novel combination therapies to combat treatment resistance and achieve long-term cancer control.
Related Concept Videos
01:27Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
01:19Psychoneuroimmunology: Diabetes and Cancer
613
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
613
01:27Cytotoxic T Cells-mediated Immune Response
7.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.9K
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
02:53Adaptive Mechanisms in Cancer Cells
4.2K
4.2K
02:17The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K